PMC3872090_01
Case 1: pretreatment photos.
ccid-7-011Fig1.jpg
PMC3872090_01_ccid-7-011Fig1.jpg
f1-ccid-7-011
The patient experienced almost no response to the first treatment (Figures 1 and 2).
Case 1: 2 weeks posttreatment photos.
ccid-7-011Fig2.jpg
PMC3872090_01_ccid-7-011Fig2.jpg
f2-ccid-7-011
The patient experienced almost no response to the first treatment (Figures 1 and 2).
PMC3872090_02
Case 2: pretreatment photos.
ccid-7-011Fig3.jpg
PMC3872090_02_ccid-7-011Fig3.jpg
f3-ccid-7-011
In May 2010, the woman received further injections with abobotulinumtoxinA (Dysport ) in the glabella, frontalis, orbicularis oculi, and platysmal bands (Table 2), but reported that the treatment was not working as well as it had been (Figures 3 and 4).
Case 2: 2 weeks posttreatment photo.
ccid-7-011Fig4.jpg
PMC3872090_02_ccid-7-011Fig4.jpg
f4-ccid-7-011
In May 2010, the woman received further injections with abobotulinumtoxinA (Dysport ) in the glabella, frontalis, orbicularis oculi, and platysmal bands (Table 2), but reported that the treatment was not working as well as it had been (Figures 3 and 4).
PMC3872090_03
PMC3872090_04
PMC3872090_05